Total Payments
$5,637
2024 Payments
$1,094
Companies
30
Transactions
249
Medicare Patients
885
Medicare Billing
$132,363
Payment Breakdown by Category
Food & Beverage$5,025 (89.2%)
Education$611.48 (10.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,025 | 238 | 89.2% |
| Education | $611.48 | 11 | 10.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,324 | 63 | $0 (2024) |
| Janssen Biotech, Inc. | $776.50 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $345.46 | 18 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $264.90 | 11 | $0 (2024) |
| Genentech USA, Inc. | $247.25 | 14 | $0 (2019) |
| Celgene Corporation | $238.05 | 11 | $0 (2024) |
| Incyte Corporation | $232.45 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $224.83 | 8 | $0 (2022) |
| Ipsen Biopharmaceuticals, Inc | $212.17 | 10 | $0 (2024) |
| Amgen Inc. | $183.06 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,094 | 49 | PFIZER INC. ($263.57) |
| 2023 | $1,039 | 42 | Janssen Scientific Affairs, LLC ($180.39) |
| 2022 | $779.34 | 33 | Janssen Biotech, Inc. ($190.28) |
| 2021 | $382.91 | 18 | PFIZER INC. ($178.35) |
| 2020 | $140.83 | 6 | PFIZER INC. ($123.79) |
| 2019 | $542.33 | 26 | Genentech USA, Inc. ($142.31) |
| 2018 | $1,239 | 58 | PFIZER INC. ($344.46) |
| 2017 | $419.39 | 17 | Millennium Pharmaceuticals, Inc. ($111.24) |
All Payment Transactions
249 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $32.24 | General |
| Category: Oncology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $20.89 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.13 | General |
| Category: Hematology/Oncology | ||||||
| 12/05/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.23 | General |
| Category: Oncology | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Oncology | ||||||
| 11/07/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TALVEY (Biological), DARZALEX, TECVAYLI | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Oncology | ||||||
| 09/19/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Oncology | ||||||
| 09/10/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/10/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/06/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Oncology | ||||||
| 08/22/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: ONCOLOGY | ||||||
| 08/07/2024 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | Cash or cash equivalent | $30.19 | General |
| Category: Hematology | ||||||
| 07/31/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Oncology | ||||||
| 07/31/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $20.36 | General |
| Category: Hematology/Oncology | ||||||
| 07/24/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Oncology | ||||||
| 07/17/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Oncology | ||||||
| 07/12/2024 | Janssen Scientific Affairs, LLC | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 225 | 636 | $214,239 | $34,559 |
| 2022 | 3 | 194 | 620 | $177,876 | $28,897 |
| 2021 | 4 | 220 | 770 | $248,783 | $43,332 |
| 2020 | 4 | 246 | 612 | $171,164 | $25,576 |
Total Patients
885
Total Services
2,638
Medicare Billing
$132,363
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 145 | $94,250 | $16,618 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 206 | $105,440 | $15,563 | 14.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 87 | 285 | $14,549 | $2,377 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 329 | $148,050 | $25,826 | 17.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $15,685 | $2,249 | 14.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 87 | 277 | $14,141 | $821.58 | 5.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 100 | 381 | $171,450 | $30,016 | 17.5% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 13 | 66 | $52,140 | $10,560 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 15 | $9,470 | $1,832 | 19.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 95 | 308 | $15,723 | $924.00 | 5.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 103 | 303 | $131,070 | $20,338 | 15.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $16,110 | $2,890 | 17.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 20 | $10,200 | $1,543 | 15.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 107 | 270 | $13,784 | $804.60 | 5.8% |
About Dr. Avi Einzig, MD
Dr. Avi Einzig, MD is a Hematology & Oncology healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245311414.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Avi Einzig, MD has received a total of $5,637 in payments from pharmaceutical and medical device companies, with $1,094 received in 2024. These payments were reported across 249 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,025).
As a Medicare-enrolled provider, Einzig has provided services to 885 Medicare beneficiaries, totaling 2,638 services with total Medicare billing of $132,363. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Bronx, NY
- Active Since 10/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1245311414
Products in Payments
- XTANDI (Drug) $449.70
- IMBRUVICA (Drug) $440.89
- IBRANCE (Drug) $423.71
- KISQALI (Drug) $297.64
- DARZALEX (Biological) $288.37
- ERLEADA (Drug) $206.27
- BOSULIF (Drug) $160.46
- ADCETRIS (Biological) $157.20
- ELIQUIS (Drug) $128.05
- Pomalyst (Drug) $116.80
- ORGOVYX (Drug) $116.50
- JAKAFI (Drug) $111.41
- VELCADE (Drug) $111.24
- Tazverik (Drug) $106.69
- SARCLISA (Biological) $101.88
- CYRAMZA (Drug) $86.03
- BENDEKA (Drug) $84.36
- Aranesp (Biological) $84.06
- SOMATULINE DEPOT (Drug) $82.80
- SUTENT (Drug) $81.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Bronx
Dr. Mark Chaitowitz, Md, MD
Hematology & Oncology — Payments: $13,776
Hematology & Oncology $13,776
Stuart Packer, Md, MD
Hematology & Oncology — Payments: $13,717
Hematology & Oncology $13,717
Mr. Howard Bruckner, M.d, M.D
Hematology & Oncology — Payments: $12,939
Hematology & Oncology $12,939
Dr. Avi Retter, Md, MD
Hematology & Oncology — Payments: $11,928
Hematology & Oncology $11,928
Dr. Ilmana Fulger, Md, MD
Hematology & Oncology — Payments: $9,395
Hematology & Oncology $9,395
Dr. Ivette Vigoda, Md, MD
Hematology & Oncology — Payments: $8,453
Hematology & Oncology $8,453